107 views | 4 months ago
Nicole Pfarr, Dipl.-Biol, discusses how tumor whole exome sequencing (WES) can provide valuable insights into mechanisms that drive tumor proliferation, survival, and response to therapy. WES has the...
91 views | 4 months ago
Nicole Pfarr, Dipl.-Biol, discusses how an in-house comprehensive genomic profiling (CGP) including HRD provides fast turnaround to guide patient treatment and improves laboratory operational efficiency....
93 views | 4 months ago
Enrique de Álava, MD, PhD explica los beneficios que aporta utilizar la secuenciación masiva (Next-Generation Sequencing) y oncología de precisión para los pacientes con carcinoma de pulmón. El Dr....
253 views | 4 months ago
Enrique de Álava, MD, PhD discusses the benefits of using NGS panels vs single-gene testing to guide treatment of non-small cell lung cancer patients (NSCLC) and explains the value of comprehensive...
122 views | 4 months ago
Caterina Marchiò, MD, PhD explains the benefits of performing in-house CGP testing vs test send-out to increase the opportunities for precision medicine for cancer patients. Dr. Marchiò presents 3 patient...
331 views | 4 months ago
Illumina presentation recorded at EACR Liquid Biopsies 2024 conference in Lyon. In this brief video (16 min), Anna Babayan outlines solutions available for liquid biopsy research, including Cell-free...
406 views | 4 months ago
Christopher Kent from the University of Birmingham introduces PrimalScheme 3 and discusses best practices for primer design to help optimize IMAP experiments. https://primalscheme.com Subscribe to...
144 views | 4 months ago
In Shanghai, Illumina showcased a range of forward-thinking technologies, products, and solutions aimed at empowering partners across industries. Subscribe to the Illumina video channel http://www.youtube.com/subscription_center?add_user=IlluminaInc...